Dissolution profiles of BCS class II drugs generated by the gastrointestinal simulator alpha has an edge over the compendial USP II method

This publication has 48 references indexed in Scilit:

• Dissolution Profiles of Poorly Soluble Drug Salts in Bicarbonate Buffer
  Pharmaceutical Research, 2023
• Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism
  Archives of Pharmacal Research, 2021
• Physiologically‐Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS‐CoV‐2
  Clinical Pharmacology & Therapeutics, 2020
• Danazol oral absorption modelling in the fasted dog: An example of mechanistic understanding of formulation effects on drug pharmacokinetics
  European Journal of Pharmaceutics and Biopharmaceutics, 2019
• Pharmacokinetics of DFN-15, a Novel Oral Solution of Celecoxib, Versus Celecoxib 400-mg Capsules: A Randomized Crossover Study in Fasting Healthy Volunteers
  Clinical Drug Investigation, 2017
• In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test media
  European Journal of Pharmaceutics and Biopharmaceutics, 2015
• Effect of gastric pH on the pharmacokinetics of a bcs class II compound in dogs: Utilization of an artificial stomach and duodenum dissolution model and gastroplus,™ simulations to predict absorption
  Journal of Pharmaceutical Sciences, 2011
• Computational Oral Absorption Simulation for Low‐Solubility Compounds
  Chemistry & Biodiversity, 2009
• Canine Intestinal Contents vs. Simulated Media for the Assessment of Solubility of Two Weak Bases in the Human Small Intestinal Contents
  Pharmaceutical Research, 2006
• Physicochemical considerations in the preparation of amorphous ritonavir–poly(ethylene glycol) 8000 solid dispersions
  Journal of Pharmaceutical Sciences, 2001